4.6 Article

An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review

Lucas Vieira dos Santos et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)

Article Oncology

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Ethan Basch et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Oncology

Use of Neurokinin-1 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Miriam P. Rogers et al.

CLINICAL JOURNAL OF ONCOLOGY NURSING (2010)

Editorial Material Pharmacology & Pharmacy

Fosaprepitant dimeglumine (MK-0517 or L-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting

Simon J. P. Van Belle et al.

EXPERT OPINION ON PHARMACOTHERAPY (2008)

Review Medicine, General & Internal

Drug therapy: Chemotherapy-induced nausea and vomiting

Paul J. Hesketh

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Pharmacology & Pharmacy

Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects

Kenneth C. Lasseter et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2007)